Author Correction: Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK.

Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
10 Oct 2019
Historique:
entrez: 11 10 2019
pubmed: 11 10 2019
medline: 11 10 2019
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41598-019-51007-0 PMID: 31597941 PMC: PMC6785556
pubmed: 31597941
doi: 10.1038/s41598-019-51007-0
pii: 10.1038/s41598-019-51007-0
pmc: PMC6785556
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

14826

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK053307
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK060596
Pays : United States
Organisme : NIDDK NIH HHS
ID : R37 DK060596
Pays : United States

Commentaires et corrections

Type : ErratumFor

Auteurs

David Danielpour (D)

Case Comprehensive Cancer Center Research Laboratories, The Division of General Medical Sciences-Oncology, Case Western Reserve University, Cleveland, OH, 44106, USA. dxd49@case.edu.
Department of Pharmacology, Case Western Reserve University, Cleveland, OH, 44106, USA. dxd49@case.edu.
Department of Urology, University Hospitals of Cleveland, Cleveland, OH, 44106, USA. dxd49@case.edu.
ORCID: 0000-0002-4020-2630

Zhaofeng Gao (Z)

Department of Genetics and Genomic Sciences, Case Western Reserve University, Cleveland, OH, 44106, USA.

Patrick M Zmina (PM)

Case Comprehensive Cancer Center Research Laboratories, The Division of General Medical Sciences-Oncology, Case Western Reserve University, Cleveland, OH, 44106, USA.

Eswar Shankar (E)

Case Comprehensive Cancer Center Research Laboratories, The Division of General Medical Sciences-Oncology, Case Western Reserve University, Cleveland, OH, 44106, USA.

Benjamin C Shultes (BC)

Case Comprehensive Cancer Center Research Laboratories, The Division of General Medical Sciences-Oncology, Case Western Reserve University, Cleveland, OH, 44106, USA.
Department of Biochemistry, Case Western Reserve University, Cleveland, OH, 44106, USA.

Raul Jobava (R)

Department of Genetics and Genomic Sciences, Case Western Reserve University, Cleveland, OH, 44106, USA.

Scott M Welford (SM)

Department of Radiation Oncology, Case Western Reserve University, Cleveland, OH, 44106, USA.
Department of Radiation Oncology, University of Miami, Coral Gables, FL, 33136, USA.
ORCID: 0000-0002-9579-4223

Maria Hatzoglou (M)

Department of Genetics and Genomic Sciences, Case Western Reserve University, Cleveland, OH, 44106, USA.

Classifications MeSH